Array BioPharma (ARRY)
Create an Alert
4.91
-0.05 -1.01%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Array BioPharma Asset Utilization:
0.6017 for March 31, 2013Array BioPharma Historical Asset Utilization Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.6017 |
| Dec. 31, 2012 | 0.5957 |
| Sept. 30, 2012 | 0.9405 |
| June 30, 2012 | 0.8192 |
| March 31, 2012 | 0.7976 |
| Dec. 31, 2011 | 0.8398 |
| Sept. 30, 2011 | 0.6645 |
| June 30, 2011 | 0.629 |
| March 31, 2011 | 0.5191 |
| Dec. 31, 2010 | 0.5511 |
| Sept. 30, 2010 | 0.4506 |
| June 30, 2010 | 0.4002 |
| March 31, 2010 | 0.3657 |
| Dec. 31, 2009 | 0.2276 |
| Sept. 30, 2009 | 0.22 |
| June 30, 2009 | 0.215 |
| March 31, 2009 | 0.1882 |
| Dec. 31, 2008 | 0.1873 |
| Sept. 30, 2008 | 0.1779 |
| June 30, 2008 | 0.1577 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
About Asset Utilization
The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns.
For example, with an asset utilization ratio of 52%, a company earned $.52 for each dollar of assets held by the company. An increasing asset utilization means the company is being more efficient with each dollar of assets it has.
This ratio is frequently used to compare a company's efficiency over time.
Learn More
ARRY Asset Utilization Benchmarks
| Companies | |
|---|---|
| Cytokinetics | 0.0826 |
| Celldex Therapeutics | 0.0645 |
| Oncothyreon | 0.00 |
ARRY Asset Utilization Rankings
| Overall |
77th percentile 3766 of 16782 |
| Sector |
71st percentile 395 of 1410 in Healthcare |
| Industry |
87th percentile 55 of 454 in Biotechnology |
ARRY Asset Utilization Range, Past 5 Years
| Minimum | 0.1577 | Jun 2008 |
| Maximum | 0.9405 | Sep 2012 |
| Average | 0.4774 |
